推进多血管冠状动脉疾病的治疗范式:混合冠状动脉再血管化
Parth M Patel1, Ryon L Arrington1, Amalia Jonsson1
1Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA.
Innovations (Philadelphia, Pa.)
|February 3, 2025
概括
混合冠状动脉再血管化 (HCR) 是对多血管冠状动脉疾病 (CAD) 的安全有效的最小侵入性选择. 用HCR进行完整的复血管化改善了长期存活率,而不完整的程序与较差的结果有关.
科学领域:
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
- 医疗技术 医疗技术 医学技术
背景情况:
- 多血管冠状动脉疾病 (CAD) 带来了重大治疗挑战.
- 传统的治疗方法,如冠状动脉旁路移植 (CABG) 和穿皮冠状动脉干预 (PCI) 有局限性.
- 混合冠状动脉再血管化 (HCR) 结合了手术和干预技术.
研究的目的:
- 评估HCR的长期安全性和有效性.
- 评估大量多血管CAD患者队列中的HCR结果.
- 为了确定HCR后不良事件的风险因素.
主要方法:
- 一组561名患有2或3血管CAD的患者在2009年至2020年期间接受了计划的HCR.
- 人权CR涉及机器人辅助下LIMA-LAD CABG和非LAD船只的PCI.
- 多变量回归分析确定了短期和长期结果的风险因素.
主要成果:
- 低的手术死亡率 (0.7%) 和中风率 (0.9%).
- 高的LIMA通透率 (98%) 和低的重复血管化率 (8%在中位数4.5年).
- 完整的复血管化与明显更好的5年生存率相关 (91%对64%).
结论:
- HCR是一种安全有效的微创替代方案,可供选择多血管CAD患者使用.
- 观察到重复血管化和死亡率较低.
- 不完全的再血管化是减少长期存活率的重要危险因素.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


